Digest Network Come funziona
Network
/
Società
Ae
Non verificato

Aegis Sciences Corporation

Di cosa scriviamo

FarmaceuticaIndustriaSaluteSanitàScienza

6 comunicati stampa

Guarda tutti i comunicati
24/06/2025
Associazioni/Professionisti
Salute
Sanità
Finanza
Farmaceutica
Banca
Titoli e azioni
Aegis Sciences Corporation Announces Successful $170 Million Debt Refinancing to Support Continued Growth
Fonte
Aegis Sciences Corporation
Emittente
Business Wire
1.00
0
03/06/2025
Scienza
Psichiatria
Attrezzature medico-sanitarie
Management
Sanità
Farmaceutica
Salute
Industria
Aegis Sciences Corporation Announces Updates for Novel Psychoactive Substances (NPS) Testing
Fonte
Aegis Sciences Corporation
Emittente
Business Wire
1.00
0
25/02/2025
Politica Interna
Salute
Scienza
Sanità
Industria
Aegis Sciences Corporation Launches MedProtectCDM to Transform Medication Adherence and Safety Monitoring for Chronic Conditions
Fonte
Aegis Sciences Corporation
Emittente
Business Wire
1.00
0
11/02/2025
Information Technology
Salute
Tecnica
Software
Farmaceutica
Industria
Aegis Sciences Corporation Launches Innovative Dashboard to Track Novel Psychoactive Substances Nationwide
Fonte
Aegis Sciences Corporation
Emittente
Business Wire
1.00
0
17/12/2024
Industria
Biotecnologia
Sanità
Politica Interna
Salute
Farmaceutica
Psichiatria
Scienza
Medicina - Varie
Aegis Sciences Corporation Collaborates with The McNabb Center to Evaluate the Impact of Xylazine Exposure on Opioid Withdrawal
Fonte
Aegis Sciences Corporation
Emittente
Business Wire
1.00
0
10/12/2024
Industria
Scienza
Organizzazione Aziendale
Associazioni/Professionisti
Biotecnologia
Salute
Farmaceutica
Sanità
Aegis Sciences Corporation Announces Updates for NPS Testing
Fonte
Aegis Sciences Corporation
Emittente
Business Wire
1.00
0

Recapiti

Social Media

Seguaci
0
Compatibilità
0